ABC News @ABC
Shares of Biogen and other drugmakers researching Alzheimer’s disease soar after Japan’s Eisai Co. says its potential treatment appeared to slow the fatal disease’s progress in a late-stage study. https://t.co/nd6XErFony — PolitiTweet.org